Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @jwnickerson from #MSF urged it (@gavi) to allow a “thorough, independent and transparent estimate” of the vaccines’ cost of manufacture to “ensure that the price paid is fair and reasonable”. #Ebola #vaccine @Merck reuters.com/article/us-hea… @MSF_access 19:28 - 05 Dec 2019